Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 1
2008 2
2009 1
2010 1
2011 2
2012 1
2015 3
2016 2
2017 2
2018 1
2021 2
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes.
Vilariño-García T, Polonio-González ML, Pérez-Pérez A, Ribalta J, Arrieta F, Aguilar M, Obaya JC, Gimeno-Orna JA, Iglesias P, Navarro J, Durán S, Pedro-Botet J, Sánchez-Margalet V. Vilariño-García T, et al. Among authors: duran s. Int J Mol Sci. 2024 Feb 16;25(4):2338. doi: 10.3390/ijms25042338. Int J Mol Sci. 2024. PMID: 38397015 Free PMC article. Review.
Nutrients and Dietary Approaches in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Narrative Review.
Jiménez-Cortegana C, Iglesias P, Ribalta J, Vilariño-García T, Montañez L, Arrieta F, Aguilar M, Durán S, Obaya JC, Becerra A, Pedro-Botet J, Sánchez-Margalet V, On Behalf Of The Cardiovascular Disease Working Group Of The Spanish Society Of Diabetes Sed. Jiménez-Cortegana C, et al. Among authors: duran s. Nutrients. 2021 Nov 19;13(11):4150. doi: 10.3390/nu13114150. Nutrients. 2021. PMID: 34836405 Free PMC article. Review.
Update on Diagnosis and Treatment of Diabetic Retinopathy: A Consensus Guideline of the Working Group of Ocular Health (Spanish Society of Diabetes and Spanish Vitreous and Retina Society).
Corcóstegui B, Durán S, González-Albarrán MO, Hernández C, Ruiz-Moreno JM, Salvador J, Udaondo P, Simó R. Corcóstegui B, et al. Among authors: duran s. J Ophthalmol. 2017;2017:8234186. doi: 10.1155/2017/8234186. Epub 2017 Jun 14. J Ophthalmol. 2017. PMID: 28695003 Free PMC article. Review.
[Diabetes mellitus and cardiovascular risk: Working group recommendations of Diabetes and Cardiovascular Disease of the Spanish Society of Diabetes (SED, 2015)].
Arrieta F, Iglesias P, Pedro-Botet J, Tébar FJ, Ortega E, Nubiola A, Pardo JL, Maldonado GF, Obaya JC, Matute P, Petrecca R, Alonso N, Sarabia E, Sánchez-Margalet V, Alemán JJ, Navarro J, Becerra A, Duran S, Aguilar M, Escobar-Jiménez F; Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED). Arrieta F, et al. Among authors: duran s. Aten Primaria. 2016 May;48(5):325-36. doi: 10.1016/j.aprim.2015.05.002. Epub 2015 May 29. Aten Primaria. 2016. PMID: 26031458 Free PMC article. Spanish.
Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021).
Arrieta F, Pedro-Botet J, Iglesias P, Obaya JC, Montanez L, Maldonado GF, Becerra A, Navarro J, Perez JC, Petrecca R, Pardo JL, Ribalta J, Sánchez-Margalet V, Duran S, Tébar FJ, Aguilar M. Arrieta F, et al. Among authors: duran s. Clin Investig Arterioscler. 2022 Jan-Feb;34(1):36-55. doi: 10.1016/j.arteri.2021.05.002. Epub 2021 Jul 28. Clin Investig Arterioscler. 2022. PMID: 34330545 English, Spanish.
Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes.
Fulcher G, Matthews DR, Perkovic V, de Zeeuw D, Mahaffey KW, Mathieu C, Woo V, Wysham C, Capuano G, Desai M, Shaw W, Vercruysse F, Meininger G, Neal B; CANVAS trial collaborative group. Fulcher G, et al. Diabetes Obes Metab. 2016 Jan;18(1):82-91. doi: 10.1111/dom.12589. Epub 2015 Dec 8. Diabetes Obes Metab. 2016. PMID: 26450639 Clinical Trial.
Discrepancies in reporting the CAG repeat lengths for Huntington's disease.
Quarrell OW, Handley O, O'Donovan K, Dumoulin C, Ramos-Arroyo M, Biunno I, Bauer P, Kline M, Landwehrmeyer GB; European Huntington’s Disease Network. Quarrell OW, et al. Eur J Hum Genet. 2012 Jan;20(1):20-6. doi: 10.1038/ejhg.2011.136. Epub 2011 Aug 3. Eur J Hum Genet. 2012. PMID: 21811303 Free PMC article.
Diabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018).
Arrieta F, Iglesias P, Pedro-Botet J, Becerra A, Ortega E, Obaya JC, Nubiola A, Maldonado GF, Campos MDM, Petrecca R, Pardo JL, Sánchez-Margalet V, Alemán JJ, Navarro J, Duran S, Tébar FJ, Aguilar M, Escobar F; Grupo de Riesgo Cardiovascular de la Sociedad Española de Diabetes (SED). Arrieta F, et al. Among authors: duran s. Clin Investig Arterioscler. 2018 May-Jun;30(3):137-153. doi: 10.1016/j.arteri.2018.03.002. Epub 2018 May 10. Clin Investig Arterioscler. 2018. PMID: 29754804 English, Spanish.
17 results